Free Trial

TD Asset Management Inc Sells 340,742 Shares of Oscar Health, Inc. $OSCR

Oscar Health logo with Finance background

Key Points

  • TD Asset Management Inc has reduced its stake in Oscar Health by 50.6%, selling 340,742 shares, which left them with 332,490 shares valued at $7.1 million.
  • Oscar Health's stock has faced significant fluctuations, with an 8.2% decrease in its price recently, currently trading around $19.31.
  • Research analysts have varied opinions on the stock, as six have rated it as a Hold and six others as a Sell, with the average target price set at $13.19.
  • MarketBeat previews top five stocks to own in November.

TD Asset Management Inc lessened its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 50.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 332,490 shares of the company's stock after selling 340,742 shares during the quarter. TD Asset Management Inc owned about 0.13% of Oscar Health worth $7,129,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. LRI Investments LLC raised its stake in shares of Oscar Health by 377.9% during the 2nd quarter. LRI Investments LLC now owns 1,233 shares of the company's stock worth $26,000 after acquiring an additional 975 shares in the last quarter. Jones Financial Companies Lllp raised its stake in shares of Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock worth $30,000 after acquiring an additional 2,242 shares in the last quarter. Strs Ohio bought a new position in shares of Oscar Health during the 1st quarter worth approximately $30,000. Larson Financial Group LLC raised its stake in shares of Oscar Health by 83,733.3% during the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock worth $33,000 after acquiring an additional 2,512 shares in the last quarter. Finally, CWM LLC raised its stake in shares of Oscar Health by 50.7% during the 1st quarter. CWM LLC now owns 3,204 shares of the company's stock worth $42,000 after acquiring an additional 1,078 shares in the last quarter. Institutional investors own 75.70% of the company's stock.

Insider Activity at Oscar Health

In other news, insider Mario Schlosser sold 395,000 shares of the company's stock in a transaction on Monday, September 22nd. The shares were sold at an average price of $18.43, for a total value of $7,279,850.00. Following the sale, the insider directly owned 501,148 shares of the company's stock, valued at $9,236,157.64. This represents a 44.08% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 24.39% of the stock is owned by company insiders.

Analysts Set New Price Targets

OSCR has been the topic of several research analyst reports. Zacks Research raised shares of Oscar Health from a "strong sell" rating to a "hold" rating in a research report on Monday, October 13th. Wells Fargo & Company boosted their target price on shares of Oscar Health from $10.00 to $14.00 and gave the stock an "underweight" rating in a research report on Tuesday, October 7th. Robert W. Baird reissued a "neutral" rating and set a $14.00 target price (down previously from $28.00) on shares of Oscar Health in a research report on Friday, July 25th. UBS Group reissued a "sell" rating and set a $11.00 target price (down previously from $15.00) on shares of Oscar Health in a research report on Tuesday, July 15th. Finally, Baird R W downgraded shares of Oscar Health from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 25th. Six research analysts have rated the stock with a Hold rating and six have issued a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of "Reduce" and an average target price of $13.19.

Read Our Latest Analysis on OSCR

Oscar Health Stock Down 8.2%

OSCR stock opened at $19.31 on Monday. The firm's fifty day simple moving average is $18.36 and its 200-day simple moving average is $16.13. The company has a market capitalization of $4.99 billion, a P/E ratio of -23.84 and a beta of 1.89. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.86 and a quick ratio of 0.86. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.80.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, beating the consensus estimate of ($0.90) by $0.01. The business had revenue of $2.86 billion for the quarter, compared to the consensus estimate of $2.88 billion. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The business's revenue for the quarter was up 29.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.20 EPS. As a group, equities research analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Oscar Health Profile

(Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Further Reading

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).

Institutional Ownership by Quarter for Oscar Health (NYSE:OSCR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Oscar Health Right Now?

Before you consider Oscar Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.

While Oscar Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.